Skip to content

Clinical study of Xijiao Dihuang Decoction in the treatment of sepsis

Clinical study of Xijiao Dihuang Decoction in the treatment of sepsis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-15006630
Enrollment
Unknown
Registered
2015-06-14
Start date
2015-06-14
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

The test group:Conventional medicine combined with traditional Chinese medicine decoction
Control:Conventional medicine only

Sponsors

Hospital of Integrated Chinese and Western medicine in Jiangsu Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic standard of septic; 2. Have not used other anti shock drug or the drug proved ineffective; 3. Between the age of 18 to 79 years,sex not limited; 4. Meet the diagnosis standard of TCM syndrome; 5. Only patients in hospital.

Exclusion criteria

Exclusion criteria: 1. In the past three moths participated in other clinical trial; 2. Mental disease patients; 3. Connective tissue disorders, the endocrine metabolic disorders such as diabetes; 4. Period of pregnancy, lactation woman; disabled patients (such as the blind,the deaf, the intelli-gence obstacle); 5. Be comfirmed or suspected of having alcohol or drug abusers; 6. Allergy; 7. The other situation not fit into the group acccording to the researcher's judgment.

Design outcomes

Primary

MeasureTime frame
Body temperature;Heart rate;The amount of urine;

Countries

China

Contacts

Public ContactZhang Aiping
zhangaiping0720@sina.com+86 13770695364

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026